- Report
- September 2025
- 280 Pages
Global
From €5109EUR$5,850USD£4,438GBP
- Report
- September 2025
- 503 Pages
Global
From €5109EUR$5,850USD£4,438GBP
- Report
- September 2025
- 201 Pages
Global
From €5109EUR$5,850USD£4,438GBP
- Report
- September 2025
- 89 Pages
Global
From €5109EUR$5,850USD£4,438GBP
- Report
- September 2025
- 271 Pages
Global
From €5109EUR$5,850USD£4,438GBP
- Report
- September 2025
- 289 Pages
Global
From €5109EUR$5,850USD£4,438GBP
- Clinical Trials
- April 2025
- 60 Pages
Global
From €1092EUR$1,250USD£948GBP
- Drug Pipelines
- April 2025
- 60 Pages
Global
From €1092EUR$1,250USD£948GBP
- Drug Pipelines
- April 2025
- 60 Pages
Global
From €1747EUR$2,000USD£1,517GBP
- Report
- March 2025
- 185 Pages
Global
From €3930EUR$4,500USD£3,414GBP
- Clinical Trials
- April 2025
- 80 Pages
Global
From €1747EUR$2,000USD£1,517GBP
- Report
- December 2024
- 145 Pages
Global
From €2760EUR$3,160USD£2,397GBP
€3450EUR$3,950USD£2,997GBP
- Report
- October 2024
- 200 Pages
Global
From €3275EUR$3,750USD£2,845GBP
- Report
- May 2025
- 120 Pages
Global
From €4148EUR$4,750USD£3,604GBP
- Report
- June 2025
- 150 Pages
Global
From €2357EUR$2,699USD£2,048GBP
- Report
- June 2025
- 200 Pages
Global
From €2436EUR$2,789USD£2,116GBP
- Report
- September 2025
- 150 Pages
Global
From €3362EUR$3,850USD£2,921GBP
- Report
- September 2025
- 150 Pages
Global
From €3362EUR$3,850USD£2,921GBP
- Report
- June 2025
- 150 Pages
Global
From €3362EUR$3,850USD£2,921GBP
€4236EUR$4,850USD£3,680GBP
- Report
- June 2025
- 150 Pages
Global
From €3362EUR$3,850USD£2,921GBP
€4236EUR$4,850USD£3,680GBP

The Stem Cell Transplant market is a subset of the larger stem cell industry. It involves the use of stem cells to treat a variety of diseases and conditions, including cancer, blood disorders, and genetic diseases. Stem cell transplants are used to replace damaged or diseased cells with healthy ones, and can be used to treat a variety of conditions.
The stem cell transplant market is a rapidly growing field, with new treatments and technologies being developed and tested. Companies in the market are focused on developing and commercializing stem cell therapies, as well as providing services related to stem cell transplantation. These companies include Celgene, Novartis, and Osiris Therapeutics. Additionally, there are a number of smaller companies that are focused on developing and commercializing stem cell therapies, such as Athersys, Inc., and Pluristem Therapeutics. Show Less Read more